Higher mRNA levels of chemokines and cytokines associated with macrophage activation in erythema migrans skin lesions in patients from the United States than in patients from Austria with Lyme Borreliosis
Abstract
BACKGROUND: Erythema migrans (EM) is caused primarily by Borrelia afzelii in Europe and solely by Borrelia burgdorferi in the United States. B. burgdorferi infection in the United States has previously been associated with faster expansion of EM lesions and with more associated symptoms, compared with B. afzelii infection in Europe. However, reasons for these differences are not yet known. METHODS: We determined the Borrelia species infecting 67 US or Austrian patients with EM. The clinical pictures and chemokine and cytokine mRNA levels in lesional skin were then compared in the 19 B. burgdorferi-infected US patients and the 37 B. afzelii-infected Austrian patients, the 2 largest groups. RESULTS: The 19 B. burgdorferi-infected US patients had faster-expanding EM lesions and a median of 4 associated signs and symptoms, whereas the 37 B. afzelii-infected Austrian patients had slower-expanding lesions and usually did not experience associated symptoms. Compared with the EM lesions of B. afzelii-infected Austrian patients, those of B. burgdorferi-infected US patients had significantly higher mRNA levels of chemokines associated with activation of macrophages, including chemoattractants for neutrophils (CXCL1), macrophages (CCL3 and CCL4), and T helper 1 cells (CXCL9, CXCL10, and CXCL11). In addition, compared with the EM lesions of Austrian patients, the EM lesions of US patients tended to have higher mRNA levels of the macrophage-associated proinflammatory cytokines interleukin 1beta and tumor necrosis factor alpha, and they had significantly higher mRNA expression of the antiinflammatory cytokines interleukin 10 and transforming growth factor beta. CONCLUSIONS: The EM lesions of B. burgdorferi-infected US patients expanded faster, were associated with more symptoms, and had higher mRNA levels of macrophage-associated chemokines and cytokines than did the EM lesions of B. afzelii-infected Austrian patients.
Key Biomarkers
Symptom Clusters
References (3)
- Chemokine Signatures in the Skin Disorders of Lyme Borreliosis in Europe: Predominance of CXCL9 and CXCL10 in Erythema Migrans and Acrodermatitis and CXCL13 in LymphocytomaInfection and Immunity · 2007
- Borrelia burgdorferi Genetic Markers and Disseminated Disease in Patients with Early Lyme DiseaseJournal of Clinical Microbiology · 2006
- Four Clones of Borrelia burgdorferi Sensu Stricto Cause Invasive Infection in HumansInfection and Immunity · 1999
Related Papers
- Human dendritic cells phagocytose and process Borrelia burgdorferiThe Journal of Immunology · 1996 · 3 shared tags
- Improving the yield of blood cultures for patients with early Lyme diseaseJournal of Clinical Microbiology · 1998 · 3 shared tags
- Complement split products C3a and C4a are early markers of acute lyme disease in tick bite patients in the United StatesInternational Archives of Allergy and Immunology · 2008 · 3 shared tags
- CD14 Mediates Cross Talk between Mononuclear Cells and Fibroblasts for Upregulation of Matrix Metalloproteinase 9 byBorrelia burgdorferiInfection and Immunity · 2007 · 3 shared tags
- Does This Patient Have Erythema Migrans?JAMA · 2007 · 3 shared tags
- Molecular and serological diagnosis of Borrelia burgdorferi infection among patients with diagnosed Erythema migransPubMed · 2007 · 3 shared tags